CIB2 Gene Deafness Autosomal Recessive Type 48 NGS Genetic DNA Test
Introduction
The CIB2 Gene Deafness Autosomal Recessive Type 48 NGS Genetic DNA Test is a state-of-the-art diagnostic tool that helps in identifying genetic mutations associated with hearing loss. Conducted using Next Generation Sequencing (NGS) technology, this test is essential for individuals who are at risk of genetic deafness, providing them with critical insights into their health.
What the Test Measures
This test specifically measures mutations in the CIB2 gene, which are linked to autosomal recessive forms of deafness. By analyzing the DNA, we can determine whether an individual carries mutations that may affect their hearing ability.
Who Should Consider This Test
Individuals who should consider this test include:
- Those with a family history of hearing loss.
- Individuals experiencing symptoms of sensorineural hearing loss.
- Patients with known genetic predispositions to ear, nose, and throat disorders.
Benefits of Taking the Test
Taking the CIB2 Gene Deafness Test offers numerous benefits:
- Early identification of genetic causes of hearing loss.
- Informed decision-making regarding treatment options.
- Understanding potential risks for future generations.
- Access to personalized genetic counseling based on results.
Understanding Your Results
Results from the CIB2 Gene Deafness Test will typically be available within 3 to 4 weeks. A genetic counselor will help interpret the findings, providing guidance on the implications of any identified mutations. This understanding can empower individuals and families to make informed health choices.
Test Pricing
Price Type | Amount (KSh) |
---|---|
Discount Price | 40,000 |
Regular Price | 56,000 |
Book Your Test Today!
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, and offer home sample collection services to ensure convenience for our patients. To book the CIB2 Gene Deafness Autosomal Recessive Type 48 NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.